Skip to main content
Back to Novo Holdings

Novo Holdings's Health Diagnostics Portfolio

Browse 4 Health Diagnostics companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.

Health Diagnostics Companies
4
Total Funding in Health Diagnostics
$216.9M

Health Diagnostics Portfolio Companies (4)

Export
BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeuroscience

Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.

Cleveland, United States
October 2025
$14.4M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical

MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.

Bangalore, India
July 2025
$47.5M
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

South San Francisco, United States
December 2024
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

Explore Novo Holdings's Full Portfolio

View all companies funded by Novo Holdings across every industry and funding stage.

View Full Novo Holdings Portfolio